Scientific Sessions 2025  /  Featured Science in EP  /  Discussant
Logo

American Heart Association

  103
  0

Final ID:

Discussant

  • Olgin, Jeffrey  ( UCSF , Larkspur , California , United States )
  • Kutyifa, Valentina  ( UNIVERSITY OF ROCHESTER , Rochester , New York , United States )
  • Exner, Derek  ( University of Calgary , Calgary , Alberta , Canada )
  • Epstein, Andrew  ( UNIV PENNSYLVANIA , Philadelphia , Pennsylvania , United States )
    • Author Disclosures:
    Jeffrey Olgin: DO have relevant financial relationships ; Consultant:VivaLNK:Active (exists now) | Valentina Kutyifa: DO have relevant financial relationships ; Research Funding (PI or named investigator):Biotronik:Active (exists now) ; Research Funding (PI or named investigator):Spire Inc.:Active (exists now) ; Research Funding (PI or named investigator):NIH:Active (exists now) ; Speaker:Medtronic:Past (completed) ; Speaker:Abbott Medical:Past (completed) ; Speaker:Boston Scientific:Past (completed) ; Consultant:ZOLL:Active (exists now) ; Research Funding (PI or named investigator):ZOLL:Past (completed) ; Research Funding (PI or named investigator):Boston Scientific:Past (completed) | Derek Exner: DO have relevant financial relationships ; Consultant:Abbott :Active (exists now) ; Ownership Interest:eMurmur :Active (exists now) ; Ownership Interest:ProtonIntel:Active (exists now) ; Ownership Interest:Clarius:Active (exists now) ; Consultant:GE Healthcare :Past (completed) ; Ownership Interest:CorVista :Active (exists now) ; Executive Role:HelpWear:Active (exists now) ; Consultant:Boston :Past (completed) ; Consultant:Medtronic :Past (completed) | Andrew Epstein: DO have relevant financial relationships ; Consultant:Abbott:Past (completed) ; Speaker:University of Pennsylvania:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Speaker:Mediasphere:Past (completed) ; Advisor:AHA:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Featured Science in EP

Monday, 11/10/2025 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
Primary Results from the Post Approval Study of a Next Generation Wearable Cardioverter Defibrillator System: the ACE-PAS Trial

Poole Jeanne, Gleva Marye, Branch Kelley, Birgersdotter-green Ulrika, Doshi Rahul, Mahankali Sridhar Arun Raghav, Wang Melinda, Gustavson Laura, Zulueta Shirley

Efficacy and safety of flecainide compared to amiodarone for atrial fibrillation cardioversion in patients with Coronary Artery Disease and preserved ejection fraction. FLECA-ED trial

Tsioufis Panagiotis-anastasios, Patsilinakos Sotirios, Kafkas Nikos, Tsioufis Konstantinos, Tsiachris Dimitris, Argyriou Nikolaos, Botis Michail, Kordalis Athanasios, Doundoulakis Ioannis, Antoniou Christos-konstantinos, Matthaiopoulos George, Zamanis Ioannis

More abstracts from these authors:
Preliminary Results from the LiLAC Study: Living Life After Cardiogenic Shock Assessing Long-Term Quality of Life Outcomes Using Novel Digital Remote Monitoring Tools

Bell Fletcher, Marogi Emily, Hernandez-pastrana Sarai, Olgin Jeffrey, O'brien Connor

Can Leadless Pacemaker Expand the Role of Subcutaneous ICD?

Lloyd Michael, Pellegrini Cara, Exner Derek

You have to be authorized to contact abstract author. Please, Login
Not Available